Skip to main content
. 2021 Dec 14;22(24):13405. doi: 10.3390/ijms222413405

Figure 17.

Figure 17

Graphical outline of the study on the combination of SLC-0111+anti-PD-1/anti-CTLA-4 immune checkpoint inhibitors reported by Chafe et al. [88].